September « 2015 « Science and Enterprise

Spinal Cord Injury Device Trial Completes Enrollment

By Alan, on September 8th, 2015%

(Michael Dorausch, Flickr)

8 September 2015. An early-stage clinical trial testing an implanted biocompatible plastic framework to encourage healing of spinal cord injuries completed its initial enrollment. The Neuro-Spinal Scaffold device is made by InVivo Therapeutics Holdings Corp. in Cambridge, Massachusetts.

Spinal cord injuries are usually caused by a sudden, traumatic blow to . . . → Read More: Spinal Cord Injury Device Trial Completes Enrollment

Labor Day 2015

By Alan, on September 7th, 2015%

7 September 2015. It’s Labor Day in the USA, so Science and Enterprise will take the day off, along with most everyone else. We’ll return to regular posting tomorrow.

In the meantime, here’s Bruce Springsteen and the E Street Band to get working people and their friends in the Labor Day spirit.

. . . → Read More: Labor Day 2015

Challenge Seeks Simple Medical Waste Incinerator

By Alan, on September 4th, 2015%

(alexroma, Pixabay)

4 September 2015. A new challenge on InnoCentive is asking the public for a design of an efficient yet simple incinerator of medical waste generated during humanitarian emergencies. The competition has a total potential payout of $30,000 and a deadline for submissions of 4 November 2015.

InnoCentive in Waltham, Massachusetts conducts . . . → Read More: Challenge Seeks Simple Medical Waste Incinerator

Hemophilia Therapy Candidate Given Breakthrough Status

By Alan, on September 4th, 2015%

(Public Domain Pictures/Pixabay)

4 September 2015. A synthetic antibody designed to prevent bleeding episodes among people with the most common type of hemophilia received a breakthrough therapy designation from the U.S. Food and Drug Administration. The pharmaceutical company Roche says FDA assigned the designation its biologic therapy code-named ACE910, now being tested in . . . → Read More: Hemophilia Therapy Candidate Given Breakthrough Status

Cancer Labs Crowdsource Drug Discovery

By Alan, on September 3rd, 2015%

Acute myeloid leukemia cells (Cancer Genome Atlas, NIH)

3 September 2015. Ontario Institute for Cancer Research and Structural Genomics Consortium are making an early-stage drug prototype freely available to the biomedical research community to further define its therapeutic capabilities. Financial and intellectual property aspects of the offer were not immediately disclosed.

The two . . . → Read More: Cancer Labs Crowdsource Drug Discovery

Technique Devised to Deliver Small Drug Amounts to Lungs

By Alan, on September 3rd, 2015%

Gordana Vunjak-Novakovic (Columbia University)

3 September 2015. Engineers and medical researchers at Columbia University developed a technique that delivers small amounts of medications in liquid form to specific areas of lungs. The team led by biomedical engineering professor Gordana Vunjak-Novakovic published its proof-of-concept findings earlier this week in Proceedings of the National Academy . . . → Read More: Technique Devised to Deliver Small Drug Amounts to Lungs

Preventive Drugs Found to Stop New HIV Infections

By Alan, on September 2nd, 2015%

Scanning electron micrograph of HIV particles infecting a human T cell (NIH.gov)

2 September 2015. A large-scale study of preexposure prophylaxis or PrEP, the use of antiviral drugs to prevent HIV infection, found the practice prevented new HIV infections among Kaiser Permanente clients in San Francisco over a 32-month period. Results of the . . . → Read More: Preventive Drugs Found to Stop New HIV Infections

Genomic Sequencing Improves Children’s Cancer Care

By Alan, on September 2nd, 2015%

(Vanessa Isabel, Wikimedia Commons)

2 September 2015. A study by medical researchers at University of Michigan shows sequencing of genomes and tumors of children with cancer provides their physicians with new information leading to changes in care given a large percentage of patients. The team led by Michigan pathology professor Arul Chinnaiyan published . . . → Read More: Genomic Sequencing Improves Children’s Cancer Care

Genome Editing Biotech Gains $70M in Venture Funds

By Alan, on September 1st, 2015%

Artist depiction of Cas9 protein editing a gene (Jennifer Doudna, University of California – Berkeley)

1 September 2015. Intellia Therapeutics, a developer of therapies that edit human genomes to fix inherited disorders, raised $70 million in its second round of venture financing. OrbiMed HealthCare Fund Management led the funding round for the Cambridge, . . . → Read More: Genome Editing Biotech Gains $70M in Venture Funds

Grant Funds Research on Nanotech Cancer Treatments

By Alan, on September 1st, 2015%

Spherical nucleic acid (Mirkin Research Group, Northwestern University)

1 September 2015. National Cancer Institute is renewing its support for a Northwestern University research center advancing nanotechnology to design new cancer treatments. The Northwestern University Center for Cancer Nanotechnology Excellence is the recipient of a new five-year, $11.7 million grant from National Cancer Institute, . . . → Read More: Grant Funds Research on Nanotech Cancer Treatments

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise